Cohen & Steers, Inc. (CNS)
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
$79.91+1.16%
Close 2026-09-04 · 1-day change
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
Intact: The reason to own it still holds.
Cohen & Steers grows revenue from $133M to $146M by 2026-Q1. Profit rose from $43M to $50M in the same period. Dividends grew from $0.59 to $0.67 per share. The company has stable management and no recent market stress.
Revenue growth is behind expectations despite efforts. Profit gains are mixed. Dividend growth faces some challenges. The stock trades expensive with fragile quality.
The price is about 35% above our fair value near $59. Analysts expect about 11% revenue growth, which is priced in. Our fair value is 23% below the Street median near $76.
Breaks if: Dividend per share falls below $0.59 in 2026-Q1
Breaks if: Operating income falls below $43M in 2026-Q1
Breaks if: Revenue falls below $133M in 2026-Q1
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
CNS represents a durable compounder with a focus on increasing revenue and enhancing operating income. The current thesis state is intact, supported by recent financial performance that remains strong compared to its industry peers.
The market seems to price in a durable premium, suggesting that investors expect continued performance. However, the valuation is considered expensive relative to peers, indicating that expectations may be high.
Management is on track with its priorities, showing consistent revenue and operating income growth. There is a moderate risk of missing earnings estimates, but the overall trajectory appears stable.
The long-term thesis hinges on the performance of sector bellwethers like BLK, BX, and KKR. If these companies continue to perform well, it could support CNS's growth; however, any negative guidance from them could impact CNS adversely.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Focus on growing revenue through expanding global real assets platform and wealth channel growth.
Stated as a priority in 3 of last 3 quarters. Revenue increased from $134.5M in 2025-Q1 to $152.7M in 2026-Q2, reflecting growth aligned with management's focus on expanding the global real assets platform and wealth channel. The trajectory is delivering consistent revenue growth.
“CEO emphasized continuing expansion of global real assets platform and wealth channel growth.”
“CEO discussed strategy to grow revenue via global real assets and wealth channel expansion.”
“CEO reiterated focus on expanding real assets and alternative income to increase revenue.”
In the next 1 to 3 years, CNS's performance will depend on its ability to maintain growth amidst high expectations and sector dynamics. Not investment advice.